Arrowhead Research Corporation (ARWR) to Present at Upcoming Scientific Conferences  
2/1/2013 6:42:04 AM

Arrowhead Research Corporation (NASDAQ: ARWR), a targeted therapeutics company, today announced that academic collaborators and scientists from the company will present data on the Dynamic PolyConjugateâ„¢ (DPC) siRNA delivery system, the ARC-520 hepatitis B drug candidate, and the Homing Peptideâ„¢ platform at upcoming scientific conferences.